Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study. (Record no. 27521019)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01888 a2200553 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517172254.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201711s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1528-0020 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1182/blood-2017-05-786137 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Malard, Florent |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20171128 |
| 245 00 - TITLE STATEMENT | |
| Title | Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Blood |
| Date of publication, distribution, etc. | 11 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2186-2195 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adrenal Cortex Hormones |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | B-Lymphocytes |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | B7-H1 Antigen |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chronic Disease |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cyclosporine |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Combinations |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Graft vs Host Disease |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphocyte Count |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rituximab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Stem Cell Transplantation |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | T-Lymphocytes, Helper-Inducer |
| General subdivision | cytology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transplantation, Homologous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Labopin, Myriam |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yakoub-Agha, Ibrahim |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chantepie, Sylvain |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guillaume, Thierry |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blaise, Didier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tabrizi, Reza |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Magro, Leonardo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vanhove, Bernard |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blancho, Gilles |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moreau, Philippe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gaugler, Béatrice |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chevallier, Patrice |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mohty, Mohamad |
| 773 0# - HOST ITEM ENTRY | |
| Title | Blood |
| Related parts | vol. 130 |
| -- | no. 20 |
| -- | p. 2186-2195 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1182/blood-2017-05-786137">https://doi.org/10.1182/blood-2017-05-786137</a> |
| Public note | Available from publisher's website |
No items available.